Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2006-07-31
2006-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
QuickVue Influenza A + B Test Field Study
NCT03417869
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
NCT01309568
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)
NCT00192231
Influenza A+B Test Kit Performance Study
NCT03895268
Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.
NCT03248960
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Swab Specimen Collection (QuickVue)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fever (\>38°C) (at time of visit or within the previous 48 hrs by history) and at least two of the following symptoms:
* Chills/sweats
* Cough
* Dyspnea (labored, difficult breathing)
* Fatigue
* Headache
* Myalgia (deep muscle aches)
* Nasal congestion
* Runny nose
* Sore throat
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Quidel Corporation
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Keller, MD
Role: PRINCIPAL_INVESTIGATOR
Sydney Airport medical Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sydney Airport Medical Centre
Mascot, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS-0119-08(B)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.